LIN vs TDOC · P/E 34, rev $33.99B vs rev $2.57B
Linde plc Ordinary Shares (LIN) versus Teladoc Inc (TDOC) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Teladoc Inc (TDOC) is a health information services company listed on NYSE.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported TDOC revenue for 2024-12-31 was $2.57B. Net income was -$1.00B. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. TDOC currently screens at market cap $1.38B.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. TDOC currently screens at market cap $1.38B.
Not investment advice. Open the LIN and TDOC stock pages for the full models.
Not investment advice.